Teemu Murtola

Activities

Activities per year 2006 2015 2017 2024

• 92 Conference presentation
• 37 Supervisor of licentiate candidate in medicine
• 10 Visit abroad
• 6 Invited lecture
• 12 More
  • 3 Position of trust in an academic community
  • 2 Evaluation of funding applications
  • 2 Pre-examination of dissertation or acting as opponent to doctoral students
  • 2 Position of trust in public sector
  • 1 Chair of workshop, panel, session or tutorial
  • 1 Membership of an organizing committee of a conference or seminar
  • 1 Public talk

Activities per year

Search results

• Eturauhassyövän hormonihoidossa olevien ikääntyneiden miesten parisuhteen ja seksuaalisuuden muutokset

  Ponsimaa, M. (Speaker), Roos, M. (Member), Ojala, H. (Member), Murtola, T. (Speaker) & Harju, E. (Speaker)

  12 Jun 2024

  Activity: Talk or presentation › Conference presentation

• Eturauhassyövän vaikutukset parisuhteeseen ja seksuaalisuuteen

  Harju, E. (Speaker) & Murtola, T. (Speaker)

  12 May 2022

  Activity: Talk or presentation › Public talk

• Eturauhassyöpäpotilaiden kokemukset ohjatusta liikuntaharjoittelusta hormonihoidon aikana

  Harju, E. (Contributor), Murtola, T. (Contributor) & Ojala, H. (Contributor)

  30 Sept 2020

  Activity: Talk or presentation › Conference presentation

• Experiences of supervised resistance exercise in prostate cancer patients undergoing androgen deprivation therapy - a pilot study

  Harju, E. (Speaker), Hakulinen, A. (Speaker), Hakulinen, A. (Speaker), Ojala, H. (Speaker) & Murtola, T. (Speaker)

  3 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Tarton yliopisto

  Murtola, T. (Visitor)

  1 Sept 2019 → 30 Jun 2020

  Activity: Visiting an external institution › Visit abroad

• Suomen urologiyhdistys, FinnProstata tutkimusryhmä (External organisation)

  Murtola, T. (Chair)

  2019 → 2024

  Activity: Membership › Position of trust in an academic community

• Julkaisufoorumi (External organisation)

  Murtola, T. (Position of trust)

  2019 → 2020

  Activity: Membership › Position of trust in public sector

• EAU Baltic Meeting 2018

  Murtola, T. (Chair)

  25 May 2018 → 26 May 2018

  Activity: Participating in or organising an event › Chair of workshop, panel, session or tutorial

• Association between NSAID, statins, and bisphosphonates and prostate cancer survival during androgen deprivation therapy in the Finnish Randomized Study of Prostate Cancer Screening

  Murtola, T. (Contributor)

  17 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Antidiabetic drugs and risk of benign prostatic hyperplasia

  Tammela, T. (Contributor), Auvinen, A. (Contributor) & Murtola, T. (Contributor)

  19 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort

  Kukko, V. (Contributor), Kaipia, A. (Contributor), Talala, K. (Contributor), Kimmo, T. (Contributor), Tammela, T. (Contributor), Auvinen, A. (Contributor) & Murtola, T. (Contributor)

  19 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Neoadjuvant chemotherapy does not increase morbidity of radical cystectomy - a 10-year nationwide study

  Salminen, A. (Contributor), Murtola, T. (Contributor) & Boström, P. (Contributor)

  18 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Blood glucose balance and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Prostate Cancer Screening

  Murtola, T. (Contributor), Auvinen, A. (Contributor) & Tammela, T. (Contributor)

  17 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Bladder cancer survival in users of HDAC-inhibiting antiepileptic drugs in a population-based cohort study

  Tammela, T. (Contributor) & Murtola, T. (Contributor)

  16 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Statins and prognosis of renal cell cancer : a retrospective Finnish cohort study

  Tammela, T. (Contributor) & Murtola, T. (Contributor)

  16 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Bladder cancer survival in men using 5-alpha-reductase inhibitors

  Mäkelä, V. (Contributor), Kotsar, A. (Contributor), Tammela, T. (Contributor) & Murtola, T. (Contributor)

  16 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Statins and renal cancer prognosis in a Finnish population-based cohort

  Eskelinen, T. (Contributor), Tammela, T. (Contributor), Kotsar, A. (Contributor) & Murtola, T. (Contributor)

  16 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Bladder cancer survival in men using 5-alpha-reductase inhibitors

  Mäkelä, V. (Speaker), Kotsar, A. (Speaker), Tammela, T. (Speaker) & Murtola, T. (Speaker)

  16 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Bladder cancer survival in users of HDAC-inhibiting antiepileptic drugs in a population-based cohort study

  Murtola, T. (Contributor)

  9 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Julkaisufoorumi (External organisation)

  Murtola, T. (Position of trust)

  2018

  Activity: Membership › Position of trust in public sector

• Opinnäytetöiden ohjaus, Lääketieteen lisensiaatin opinnäytetyö: Renal cancer incidence among users of 5alpha-reductase inhibitors and alpha-blockers

  Murtola, T. (Examiner)

  2018 → 2020

  Activity: Evaluation, examination and supervision › Supervisor of licentiate candidate in medicine

• Suomen urologiyhdistys, FinnProstata tutkimusryhmä (External organisation)

  Murtola, T. (Chair)

  2018

  Activity: Membership › Position of trust in an academic community

• Opinnäytetöiden ohjaus, Lääketieteen lisensiaatin opinnäytetyö: SERUM TOTAL CHOLESTEROL AND CANCER MORTALITY IN A POPULATION-BASED COHORT OF FINNISH MEN

  Murtola, T. (Examiner)

  2018 → 2020

  Activity: Evaluation, examination and supervision › Supervisor of licentiate candidate in medicine

• Rintasyövän levinneisyys ja ennuste diabeetikoilla suomalaisessa väestöpohjaisessa kohortissa

  Murtola, T. (Speaker)

  17 Nov 2017

  Activity: Talk or presentation › Conference presentation

• Anticoagulants and cancer mortality in the Finnish Randomized Study of Screening for Prostate Cancer

  Kinnunen, P. (Contributor), Murtola, T. (Contributor), Talala, K. (Contributor), Kimmo, T. (Contributor), Tammela, T. (Contributor) & Auvinen, A. (Contributor)

  8 Nov 2017

  Activity: Talk or presentation › Conference presentation

• Anticoagulants and cancer mortality in the Finnish Randomized Study of Screening for Prostate Cancer

  Murtola, T. (Contributor)

  8 Nov 2017

  Activity: Talk or presentation › Conference presentation

• Väitöskirjan esitarkastus

  Murtola, T. (Pre-examiner or opponent of dissertation)

  19 Oct 2017

  Activity: Evaluation, examination and supervision › Pre-examination of dissertation or acting as opponent to doctoral students

• Väitöskirjan esitarkastus

  Murtola, T. (Pre-examiner or opponent of dissertation)

  5 Aug 2017

  Activity: Evaluation, examination and supervision › Pre-examination of dissertation or acting as opponent to doctoral students

• Harvard School of Public Health

  Murtola, T. (Visitor)

  16 May 2017

  Activity: Visiting an external institution › Visit abroad

• Fasting blood glucose and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer

  Murtola, T. (Speaker), Vihervuori, V. (Speaker), Lahtela, J. (Speaker), Talala, K. (Speaker), Kimmo, T. (Speaker), Tammela, T. (Speaker) & Auvinen, A. (Speaker)

  14 May 2017

  Activity: Talk or presentation › Conference presentation

• Effect of 5-alfa reductase inhibitor usage on outcomes of prostate cancer screening

  Murtola, T. (Keynote speaker), Virkku, A. (Keynote speaker), Talala, K. (Keynote speaker), Stenman, U.-H. (Keynote speaker), Kimmo, T. (Keynote speaker), Tammela, T. (Keynote speaker) & Auvinen, A. (Keynote speaker)

  14 May 2017

  Activity: Talk or presentation › Invited lecture

• Cancer mortality by antiarrhythmic drug use in a population-based cohort of Finnish men

  Murtola, T. (Contributor)

  4 Apr 2017

  Activity: Talk or presentation › Conference presentation

• Atorvastatin and prostate cancer - a phase 2 clinical trial

  Murtola, T. (Contributor)

  4 Apr 2017

  Activity: Talk or presentation › Conference presentation

• Breast cancer extent and survival in diabetic women in a Finnish population-based cohort

  Murtola, T. (Contributor)

  4 Apr 2017

  Activity: Talk or presentation › Conference presentation

• Upper tract urothelial carcinoma: stage and prognosis among statin users in a Finnish population-based cohort

  Murtola, T. (Contributor)

  27 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Statin use and prognosis of the upper tract urothelial carcinoma in a Finnish population-based cohort

  Hurskainen, H. (Contributor), Kotsar, A. (Contributor), Tammela, T. (Contributor) & Murtola, T. (Contributor)

  27 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Risk of benign prostatic hyperplasia in users of non-steroidal anti-inflammatory drugs

  Murtola, T. (Contributor), Nygård, L. (Contributor), Talala, K. (Contributor), Kimmo, T. (Contributor), Tammela, T. (Contributor) & Auvinen, A. (Contributor)

  26 Mar 2017

  Activity: Talk or presentation › Conference presentation

• The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia

  Murtola, T. (Contributor), Auvinen, A. (Contributor) & Tammela, T. (Contributor)

  26 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Outcomes of PSA-based prostate cancer screening among men using non-steroidal anti-inflammatory drugs

  Murtola, T. (Contributor), Auvinen, A. (Contributor) & Tammela, T. (Contributor)

  25 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Atorvastatin before prostatectomy and prostate cancer - a randomized, double-blind, placebo-controlled trial

  Murtola, T. (Contributor), Heino-Tolonen, T. (Contributor), Riikonen, J. (Contributor), Syvälä, H. (Contributor), Tolonen, T. (Contributor), Koskimäki, J. (Contributor), Pakarainen, T. (Contributor), Kaipia, A. (Contributor), Isotalo, T. (Contributor), Kujala, P. (Contributor) & Tammela, T. (Contributor)

  25 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Neoadjuvant chemotherapy does not increase morbidity or mortality from radical cystectomy : 10-year national data from Finland with propensity score analyses

  Salminen, A. (Speaker), Koskinen, I. (Speaker), Montoya Perez, I. (Speaker), Hurme, S. (Speaker), Murtola, T. (Speaker), Vaarala, M. (Speaker), Nykopp, T. (Speaker), Seppänen, M. (Speaker), Isotalo, T. (Speaker), Marttila, T. (Speaker), Levomäki, L. (Speaker), Becker, S. (Speaker), Anttinen, M. (Speaker), Säily, M. (Speaker), Pogodin-Hannolainen, D. (Speaker), Viitanen, J. (Speaker), Palmberg, C. (Speaker), Ottelin, J. (Speaker), Matomäki, J. (Speaker), Sairanen, J. (Speaker) & Boström, P. (Speaker)

  10 Feb 2017

  Activity: Talk or presentation › Conference presentation

• Virtsaputken sulkijaproteesileikkaukset virtsan ponnistuskarkailun hoitona kolmessa yliopistosairaalassa vuosina 2001 - 2013

  Tammela, T. (Speaker) & Murtola, T. (Speaker)

  10 Feb 2017

  Activity: Talk or presentation › Conference presentation

• Statiinien käytön yhteys ylävirtsateiden uroteelikarsinooman levinneisyyteen ja ennusteeseen

  Tammela, T. (Speaker) & Murtola, T. (Speaker)

  10 Feb 2017

  Activity: Talk or presentation › Conference presentation

• 5-alfareduktaasin estäjien käytön yhteys virtsarakkosyöpäkuoleman riskiin

  Tammela, T. (Speaker) & Murtola, T. (Speaker)

  10 Feb 2017

  Activity: Talk or presentation › Conference presentation

• Atorvastatiinin lyhyen aikavälin vaikutus eturauhassyöpään : satunnaistettu, lumekontrolloitu ja kaksoissokkoutettu faasi 2 kliininen tutkimus

  Murtola, T. (Speaker), Syvälä, H. (Speaker) & Tammela, T. (Speaker)

  10 Feb 2017

  Activity: Talk or presentation › Conference presentation

• 360 degrees around prostate cancer

  Murtola, T. (Organiser)

  20 Jan 2017 → 21 Jan 2017

  Activity: Participating in or organising an event › Membership of an organizing committee of a conference or seminar

• Opinnäytetöiden ohjaus, Lääketieteen lisensiaatin opinnäytetyö: Access and concentrations of atorvastatin in the prostate in men with prostate cancer

  Murtola, T. (Examiner)

  2017 → 2018

  Activity: Evaluation, examination and supervision › Supervisor of licentiate candidate in medicine

• Opinnäytetöiden ohjaus, Lääketieteen lisensiaatin opinnäytetyö: Robottiavusteisen eturauhasen poistoleikkauksen tulokset TAYS:ssa 2015-2016 - endopelvisten faskioiden säästämisen vaikutus

  Murtola, T. (Examiner)

  2017 → …

  Activity: Evaluation, examination and supervision › Supervisor of licentiate candidate in medicine

• Opinnäytetöiden ohjaus, Lääketieteen lisensiaatin opinnäytetyö: Prostatektomian jälkeisen PSA-etäseurannan toimivuus Taysissa

  Murtola, T. (Examiner)

  2017 → 2018

  Activity: Evaluation, examination and supervision › Supervisor of licentiate candidate in medicine

• Opinnäytetöiden ohjaus, Lääketieteen lisensiaatin opinnäytetyö: SNPs in genes affecting warfarin metabolism modify the risk association between warfarin use and cancer mortality

  Murtola, T. (Examiner)

  2017 → 2020

  Activity: Evaluation, examination and supervision › Supervisor of licentiate candidate in medicine